CVS Corp (CVS) 97.43 $CVS Covered Call reports for

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
CVS Corp (CVS) 97.43 $CVS

Covered Call reports for Kinder Morgan, Valero Energy, SodaStream, CVS Caremark and AmerisourceBergen include trade ideas that offer returns of 20% or more!
PR Newswire - Wed Aug 03, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for ABC, CVS, KMI, SODA, and VLO.
KMI: 20.13 (+0.34), VLO: 54.71 (+2.36), ABC: 89.89 (+0.46), CVS: 97.43 (-0.63), SODA: 27.48 (-0.77)

CVS Health, Adapt Pharma Team Up to Discount NARCAN Price
Zacks Equity Research - Zacks Investment Research - Tue Aug 02, 5:38PM CDT
CVS Health and Adapt Pharma recently announced a partnership aimed at making the opioid overdose-reversing drug NARCAN Nasal Spray more affordable for patients without insurance coverage.
BABY: 38.40 (-0.05), MASI: 53.18 (+0.64), CVS: 97.43 (-0.63), MLAB: 105.13 (-3.14)

Business Highlights
By The Associated Press - AP - Tue Aug 02, 4:19PM CDT
___
F: 12.13 (+0.19), PFE: 35.29 (-1.10), GM: 30.24 (+0.31), CVS: 97.43 (-0.63), TM: 110.07 (+0.10), PG: 85.97 (-0.79), AET: 116.86 (+1.15)

Royal Caribbean and General Motors fall; CVS advances
AP - Tue Aug 02, 3:51PM CDT
NEW YORK (AP) — Stocks that moved substantially or traded heavily on Tuesday:
MNK: 79.66 (+2.75), DISCK: 25.91 (+0.50), F: 12.13 (+0.19), DAL: 36.48 (+0.09), PFE: 35.29 (-1.10), STX: 30.73 (+0.08), DISCB: 25.82 (-0.03), DISCA: 26.83 (+0.41), CVS: 97.43 (-0.63), GM: 30.24 (+0.31)

CVS Health (CVS) Tops Q2 Earnings, Lags on Revenue, View Up
Zacks Equity Research - Zacks Investment Research - Tue Aug 02, 3:39PM CDT
CVS Health Corporation (CVS) reported second-quarter 2016 adjusted earnings per share (EPS) of $1.32, up 8.2% year over year.
LMAT: 17.59 (+0.20), QDEL: 23.02 (+0.30), CVS: 97.43 (-0.63), NUVA: 62.76 (+0.13)

Watch for CVS Caremark to Potentially Pullback After Gaining 4.55% Yesterday
Comtex SmarTrend(R) - Tue Aug 02, 11:55AM CDT
CVS Caremark (NYSE:CVS) traded in a range yesterday that spanned from a low of $95.62 to a high of $98.42. Yesterday, the shares gained 4.5%, which took the trading range above the 3-day high of $94.05 on volume of 6.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CVS: 97.43 (-0.63)

CVS Caremark Rises 4.55% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Tue Aug 02, 11:54AM CDT
CVS Caremark (NYSE:CVS) traded in a range yesterday that spanned from a low of $95.62 to a high of $98.42. Yesterday, the shares gained 4.5%, which took the trading range above the 3-day high of $94.05 on volume of 6.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CVS: 97.43 (-0.63)

Q2 Earnings Reports Come in Mixed, Futures Down Slightly
Mark Vickery - Zacks Investment Research - Tue Aug 02, 8:58AM CDT
Q2 earnings season may have passed the midway point last week, but plenty of important companies are reporting earnings this morning: PFE, PG, MNT, CVS, SODA and RCL.
RCL: 68.77 (+1.42), PFE: 35.29 (-1.10), CVS: 97.43 (-0.63), PG: 85.97 (-0.79), SODA: 27.48 (-0.77)

Kleenex® Facial Cleansing Products Now Available Through World's Largest E-tailers
PR Newswire - Tue Aug 02, 7:37AM CDT
Kleenex® brand, the inventor of the facial tissue category and trusted for its exceptional softness, announces the roll-out of its Kleenex® Facial Cleansing collection across major e-tailers, including Amazon, Target.com, Walmart.com, CVS.com, Fresh Direct, Peapod, Walgreens.com and Ulta.com beginning late July 2016 and continuing through early September. All retail sites will offer products from the collection, which includes the Facial Cleansing Wipes, Exfoliating Cushions, Eye Makeup Removers and Cotton Soft Pads.
KMB: 128.89 (-1.92), CVS: 97.43 (-0.63)

CVS Health (CVS) Beats Earnings, Misses Revenues in Q2
Aparajita Dutta - Zacks Investment Research - Tue Aug 02, 7:34AM CDT
CVS Health's (CVS0 adjusted earnings per share of $1.32 beat the Zacks Consensus estimate by 1.5%.
CVS: 97.43 (-0.63)

CVS Health Reports Second Quarter Results
PR Newswire - Tue Aug 02, 5:55AM CDT
Second Quarter Year-over-year Highlights:
CVS: 97.43 (-0.63)

3 Stocks to Watch Before the Market Opens Tomorrow
ESTMZ - Mon Aug 01, 3:46PM CDT
CVS : The pharmacy giant is coming off a better than expected first quarter which saw sales rise by 19% and earnings jump by 4%. Unfortunately, investors didn’t see any of those gains as the stock is down 4% year to date. Key factors for the quarter...
RCL: 68.77 (+1.42), SPY: 216.18 (+0.63), CCL: 45.63 (+0.37), TGT: 74.10 (+0.21), CVS: 97.43 (-0.63), SODA: 27.48 (-0.77)

CVS Health to Increase Access to FDA-approved Nasal Naloxone for Patients without Insurance through Improved Affordability of NARCAN® Nasal Spray at CVS Pharmacy Locations
PR Newswire - Fri Jul 29, 9:11AM CDT
CVS Health (NYSE: CVS) and Adapt Pharma (www.AdaptPharma.com) today announced a new partnership that will make the opioid overdose-reversing drug NARCAN® (Naloxone HCl) Nasal Spray more affordable for patients without insurance at CVS Pharmacy locations. Through this partnership, CVS Pharmacy patients purchasing NARCAN® Nasal Spray without insurance will receive a $35 discount coupon to purchase the medication, reducing the out-of-pocket cost by nearly 25 percent. NARCAN® Nasal Spray is the first and only FDA-approved, ready-to-use nasal formulation of naloxone for the emergency treatment of opioid overdose. NARCAN® Nasal Spray is available in a convenient box containing two units (each unit delivers a concentrated 4mg dose of active medication-naloxone hydrochloride- in a .1ml mist) for immediate use if the need arises.
CVS: 97.43 (-0.63)

Stock Market News for July 28, 2016
Zacks Equity Research - Zacks Investment Research - Thu Jul 28, 9:10AM CDT
Benchmarks closed mixed on Wednesday following the Federal Open Market Committee’s (FOMC) policy statement and key earnings results.
KO: 43.64 (+0.11), PM: 99.03 (-0.94), XOM: 87.49 (+0.45), COST: 166.12 (-0.38), CVS: 97.43 (-0.63), PG: 85.97 (-0.79), MO: 66.37 (-0.97), CVX: 100.61 (+1.02), BA: 131.87 (+0.27), CMCSA: 66.84 (-0.06), AAPL: 105.79 (+1.31)

CVS Health (CVS) Q2 Earnings: What's in the Cards?
Zacks Equity Research - Zacks Investment Research - Wed Jul 27, 5:43PM CDT
CVS Health Corporation (CVS) is scheduled to report its second-quarter 2016 results before the opening bell on Aug 2.
ZBH: 130.43 (-0.16), CVS: 97.43 (-0.63), BMY: 74.80 (-0.25), HOLX: 39.00 (-0.03)

SmarTrend Watching for Potential Pullback in Shares of CVS Caremark After 1.05% Gain
Comtex SmarTrend(R) - Wed Jul 13, 11:51AM CDT
CVS Caremark (NYSE:CVS) traded in a range yesterday that spanned from a low of $96.53 to a high of $97.69. Yesterday, the shares gained 1.0%, which took the trading range above the 3-day high of $97.21 on volume of 2.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CVS: 97.43 (-0.63)

CVS Health (CVS) Works to Cut Down on Readmission Rates
Zacks Equity Research - Zacks Investment Research - Mon Jul 11, 5:33PM CDT
The study on medication reconciliation program by CVS Health resulted in total savings of over $1300 per patient.
HLF: 67.04 (+0.25), DPLO: 37.02 (+1.04), CVS: 97.43 (-0.63)

MinuteClinic Announces New Travel Health Services Just in Time for Summer Vacation Season
PR Newswire - Thu Jul 07, 7:00AM CDT
To help patients prepare for a safe and healthy travel season this summer and beyond, MinuteClinic, the walk-in medical clinics inside select CVS Pharmacy and Target stores nationwide, has added several new travel-related services and immunizations.
CVS: 97.43 (-0.63)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Lymphatic Research Gains Attention Beyond Wellness Claims

Updated Category News Views 488

Ankles leave little clues after a long day: sock grooves, puffiness, that dull heaviness nobody bothers to name. PureHealth Research wants people to look past the usual salt-and-water explanation and consider the lymphatic system, the body’s comparatively unsung network for gathering fluid from tissues and returning it to the bloodstream. Fair enough. This system does...

Continue Reading
PettiChat’s Digital Pet Twin Has Real Consumer Pull

Updated Category News Views 389

A Collar Gadget Is Chasing the Empty-House Problem Leave a dog or cat alone for a few hours and plenty of owners turn into amateur detectives. Did the cat eat? Has the dog been pacing? Why was that one weird noise caught on the home camera? Seattle startup PettiChat is trying to turn that itch into a product category with PettiLive!, a screen-based version of a pet that...

Continue Reading
Sitting, Lymph Flow, and a Supplement Maker's Pitch

Updated Category News Views 299

By late afternoon, a chair can feel like it has quietly won the argument against your legs. PureHealth Research is leaning into that familiar heavy, puffy-legged feeling with a reminder about lymphatic flow—and, naturally, an eight-ingredient supplement positioned alongside it. The broad message is sensible. The sales layer needs the usual healthy squint. Movement Does...

Continue Reading
Fractional CIOs Bring Order to Growing Technology Chaos

Updated Category News Views 248

A company can outgrow its technology habits long before anyone notices the smoke. One day the owner is approving another software subscription, the office manager is chasing an internet provider, and the tech person is putting out password fires. None of that looks dramatic in isolation. Together, it is a business operating without a map. That is the useful point in the...

Continue Reading
Human Frontier Mission Puts AI Research on Display

Updated Category News Views 348

A laboratory notebook is about to become the real product in this AI experiment. Human Frontier Mission, or HFM, says it will launch globally on Nov. 24, opening a research program where domain specialists frame scientific and engineering problems while autonomous AI agents develop and test possible answers. The unusual bit is not merely handing models difficult work. It...

Continue Reading
Ajman Memory Gives Heritage a Durable Digital Backbone

Updated Category News Views 303

Archives usually get applause only after somebody realizes a piece of history has vanished. Ajman is trying to skip that miserable part. During the Ajman Media Forum 2026, held November 18 and 19 at the Emirates Hospitality Centre, the emirate launched Ajman Memory, a project built to collect, document and preserve photographs, papers and video recording its development....

Continue Reading
UAE Trust Model Faces Its Hardest Test During Crisis

Updated Category News Views 371

A country’s reputation is usually invisible right up until the machinery rattles. Then people, investors, trading partners and residents stop listening to polished slogans and start watching whether airports function, services hold up, information arrives, and business can keep moving. That was the useful core of Saeed Al Eter’s remarks at Ajman Media Forum 2026: soft...

Continue Reading
Fluence Investors Face a November 27 Litigation Clock

Updated Category News Views 347

Six calendar squares are all that separate eligible Fluence investors from the November 27, 2026 lead-plaintiff deadline. That is not much time to locate trade confirmations, calculate losses, and decide whether taking a larger role in a securities case makes sense. The lawsuit is not a verdict, and anybody pretending otherwise is selling smoke. But the underlying...

Continue Reading
UAE Ties Diplomacy, Media and AI Into a Shared Signal

Updated Category News Views 128

Influence is getting harder to measure, and easier to squander, which is why the message from Ajman deserves more than a polite nod. At the 2026 Ajman Media Forum, THE SIGNAL, Foreign Affairs Undersecretary Omar Obaid Alhesan Alshamsi made the UAE’s position plain: diplomacy and media are no longer separate lanes. Both operate on words, context, trust and the difficult...

Continue Reading
3TREES Tests a Bigger Asia-Pacific Growth Blueprint

Updated Category News Views 386

A bucket of paint rarely sounds strategic until it sits inside a regional supply chain. That is the useful part of 3TREES chairman and president Hong Jie's message from the Asia-Pacific Economic Cooperation CEO Summit in Shenzhen on November 17-18, 2026: coatings are not merely a commodity if the supplier can bring materials, energy savings, technical know-how and...

Continue Reading

Top 5 Most Recently Viewed Articles

Hippo's Q3 2024 Results Showcase Growth and Financial Strength

Updated Category News Views 343

Hippo's Remarkable Financial Performance in Q3 2024 Hippo (NYSE: HIPO), a leader in home insurance dedicated to proactive protection, has unveiled its financial highlights for the third quarter of 2024. This announcement celebrates a continuation of their success, driven by strategic initiatives aimed at achieving profitable growth. Strong Revenue Growth Hippo reported...

Continue Reading
Alloy Personal Training's New Partnership Sets Growth Strategy

Updated Category News Views 225

Alloy Personal Training Partners with CapitalSpring for Expansion Alloy Personal Training recently announced an innovative collaboration with a reputable investment firm to boost its franchise growth and reach across the nation. This strategic partnership marks a notable chapter in the company’s history, reinforcing its commitment to a people-centric business model...

Continue Reading
Intel's Strategic Path Forward: Long-Term Growth in Focus

Updated Category News Views 918

Intel's Long-Term Commitment to Foundry Services Intel Corp (NASDAQ: INTC) has recently shared its strategic vision with employees, highlighting a gradual approach to growth instead of seeking quick profits. Analysts report that while there may not be any revolutionary announcements on the horizon, Intel's plans and intentions are coming into clearer focus. Analyst Harlan...

Continue Reading
Game-Changing PR: Good At Marketing's Exclusive Software

Updated Category News Views 41

Earned Media: The Overlooked Goldmine South Florida's advertising scene is a bit like a crowded beach with everyone scrambling for the same spot of sand. But Good At Marketing, based in Boynton Beach, is wading in deeper waters. They've cracked the code to something their competition hasn't even considered: earned media. Not your basic ad buy, this agency says earned...

Continue Reading
Zevra Therapeutics Reveals Impressive 2024 Financial Results

Updated Category News Views 236

Zevra Therapeutics Reports Strong Financial Results for 2024 In a significant step forward, Zevra Therapeutics, Inc. (NASDAQ: ZVRA) has released its financial results for the full year of 2024, reporting impressive net revenues of $23.6 million. This figure includes remarkable fourth-quarter contributions, with net revenue reaching $12.0 million. Company's Strategic Moves...

Continue Reading